ATF5 and neoplasm: Further, a recent study by Huang et al. describes a novel approach to targeting ATF5 where apolipoprotein E3 high density lipoprotein is loaded with siRNA and calcium phosphate, and delivered to glioblastoma xenografts in vivo to inhibit tumor growth [79].